Inogen CEO and president Scott Wilkinson announced his intention to retire from both of his positions and as a member of the Board of Directors before the end of next year. Wilkinson plans to remain in his current position until his successor is appointed while assisting the board in the search for his replacement. “On […]
Inogen
MedTech 100 roundup: Stocks open strong in May
Medtech stocks took a dip as April came to a close, but opened May with a strong week as the COVID-19 pandemic continues to affect the economy. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 83.98 points at the end of last week (May 8). That […]
Inogen plummets after Q1 losses
Inogen (NSDQ:INGN) shares took a big hit today on first-quarter results that beat the consensus forecast despite significant losses. The in-home respiratory product developer saw its shares fall -17.5% at $43.63 per share in mid-morning trading. The Goleta, Calif.-based company posted losses of -$1.6 million, or -7¢ per share, on sales of $83.1 million for the […]
Inogen reports Q4 misses, reduced guidance
Inogen (NSDQ:INGN) shares skyrocketed today on fourth-quarter results that missed the consensus earnings forecast but beat The Street’s sales projections. The Goleta, Calif.-based home oxygen generator maker posted losses of -$1.4 million, or -6¢ per share, on sales of $78.9 million for the three months ended Dec. 31, 2019, sliding into losses after posting profits […]
Inogen dives on Q1 misses, lowered outlook
Shares of Inogen (NSDQ:INGN) came under intense pressure today after the home oxygen generator maker yesterday posted first-quarter results that missed the mark on Wall Street and lowered its top-line outlook for the rest of the year. Goleta, Calif.-based Inogen said profits slid -49.5% to $5.4 million, or 24¢ per share, on sales growth of 15.3% […]
Short-seller Muddy Waters picks new medtech target: Inogen
Shares in Inogen have fallen nearly 3% today after short-selling firm Muddy Waters released a new research report calling into question the portable oxygen concentrator developer’s total addressable market and suggesting the company “created an egregiously false narrative.” In its report, Muddy Waters claims that the total addressable market for Inogen’s products “is actually shrinking,” […]
Inogen reveals rental customer data breach
Inogen today announced it was the victim of a data breach in which employee email messages containing sensitive customer information were accessed from an external agent without authorization. The Goleta, Calif.-based company said that messages were accessed externally between January 2 and March 14 this year, and contained attached files that “may have contained personal […]
Zimmer Biomet elevates Delp to Americas prez | Personnel Moves | January 22, 2017
Zimmer Biomet (NYSE:ZBH) said this week it tapped Robert Delp as its new Americas president, lifting him from his previous position as VP of US sales. Delp will replace former Americas prez Stuart Kleopfer, who is retiring from the position but will continue to work with the company while Delp transitions into his position. The shift […]
Inogen delays earnings on ‘potential accounting matters’
2014: The year of the medtech IPO | Medtech Wall Street news for the week of December 15, 2014
Inogen affirms 2014 outlook, predicts 2015 growth of up to 25%
